|
Acumen Pharmaceuticals, Inc.
|
ABOS
|
██%
|
$190M
|
x
|
2,7x
|
|
Abpro Holdings, Inc.
|
ABP
|
██%
|
$310K
|
x
|
0,0x
|
|
Abpro Holdings, Inc.
|
ABPO
|
██%
|
$340K
|
x
|
x
|
|
Arcellx, Inc.
|
ACLX
|
██%
|
$6.65B
|
x
|
16,5x
|
|
Alpha Cognition Inc.
|
ACOG
|
██%
|
$139M
|
x
|
2,2x
|
|
Adaptimmune Therapeutics Plc
|
ADAP
|
██%
|
$77M
|
-13,2x
|
-11,8x
|
|
Adma Biologics, Inc.
|
ADMA
|
██%
|
$2.20B
|
15,0x
|
4,6x
|
|
Adaptive Biotechnologies Corp
|
ADPT
|
██%
|
$2.06B
|
x
|
9,4x
|
|
Adverum Biotechnologies, Inc.
|
ADVM
|
██%
|
$95M
|
-1,8x
|
2,2x
|
|
Agenus Inc
|
AGEN
|
██%
|
$156M
|
1355,6x
|
x
|
|
Agentix Corp.
|
AGTX
|
██%
|
$2M
|
x
|
x
|
|
Aim Immunotech Inc.
|
AIM
|
██%
|
$4M
|
x
|
x
|
|
Aim Immunotech Inc.
|
AIMI
|
██%
|
$1M
|
x
|
x
|
|
Alector, Inc.
|
ALEC
|
██%
|
$265M
|
x
|
8,6x
|
|
Aligos Therapeutics, Inc.
|
ALGS
|
██%
|
$49M
|
x
|
0,9x
|
|
Allogene Therapeutics, Inc.
|
ALLO
|
██%
|
$601M
|
x
|
2,1x
|
|
Alvotech
|
ALVO
|
██%
|
$1.06B
|
x
|
x
|
|
Amgen Inc
|
AMGN
|
██%
|
$183.19B
|
23,8x
|
21,2x
|
|
Apogee Therapeutics, Inc.
|
APGE
|
██%
|
$5.70B
|
x
|
x
|
|
Aptose Biosciences Inc.
|
APTOF
|
██%
|
$4M
|
x
|
x
|
|
Argenx Se
|
ARGX
|
██%
|
$47.37B
|
x
|
x
|
|
Armata Pharmaceuticals, Inc.
|
ARMP
|
██%
|
$438M
|
x
|
x
|
|
Artiva Biotherapeutics, Inc.
|
ARTV
|
██%
|
$163M
|
x
|
1,5x
|
|
Leonabio, Inc.
|
ATHA
|
██%
|
$23M
|
-0,2x
|
0,9x
|
|
Atara Biotherapeutics, Inc.
|
ATRA
|
██%
|
$39M
|
1,2x
|
x
|
|
Atyr Pharma Inc
|
ATYR
|
██%
|
$78M
|
x
|
1,2x
|
|
Aura Biosciences, Inc.
|
AURA
|
██%
|
$431M
|
x
|
3,2x
|
|
Autolus Therapeutics Plc
|
AUTL
|
██%
|
$391M
|
x
|
2,2x
|
|
Anavex Life Sciences Corp.
|
AVXL
|
██%
|
$283M
|
x
|
2,2x
|
|
Bioatla, Inc.
|
BCAB
|
██%
|
$7M
|
x
|
x
|
|
Biocardia, Inc.
|
BCDA
|
██%
|
$13M
|
x
|
14,5x
|
|
Brainstorm Cell Therapeutics Inc.
|
BCLI
|
██%
|
$10M
|
x
|
x
|
|
Biocryst Pharmaceuticals Inc
|
BCRX
|
██%
|
$2.45B
|
9,3x
|
x
|
|
Black Diamond Therapeutics, Inc.
|
BDTX
|
██%
|
$143M
|
6,4x
|
1,3x
|
|
Beam Therapeutics Inc.
|
BEAM
|
██%
|
$2.59B
|
x
|
2,1x
|
|
Biogen Inc.
|
BIIB
|
██%
|
$26.41B
|
20,4x
|
1,5x
|
|
Biontech Se
|
BNTX
|
██%
|
$23.29B
|
x
|
x
|
|
Cabaletta Bio, Inc.
|
CABA
|
██%
|
$310M
|
x
|
2,8x
|
|
Candel Therapeutics, Inc.
|
CADL
|
██%
|
$363M
|
x
|
7,0x
|
|
C4 Therapeutics, Inc.
|
CCCC
|
██%
|
$281M
|
x
|
1,1x
|
|
Cidara Therapeutics, Inc.
|
CDTX
|
██%
|
$6.49B
|
-1,0x
|
15,4x
|
|
Creative Medical Technology Holdings, Inc.
|
CELZ
|
██%
|
$8M
|
x
|
1,1x
|
|
Cero Therapeutics Holdings, Inc.
|
CERO
|
██%
|
$680K
|
x
|
x
|
|
Cullinan Therapeutics, Inc.
|
CGEM
|
██%
|
$901M
|
x
|
2,2x
|
|
Compugen Ltd
|
CGEN
|
██%
|
$234M
|
3,3x
|
2,3x
|
|
Cg Oncology, Inc.
|
CGON
|
██%
|
$5.56B
|
x
|
7,4x
|
|
Cognition Therapeutics Inc
|
CGTX
|
██%
|
$76M
|
x
|
2,2x
|
|
Coherus Oncology, Inc.
|
CHRS
|
██%
|
$247M
|
1,5x
|
4,1x
|
|
Calidi Biotherapeutics, Inc.
|
CLDI
|
██%
|
$3M
|
x
|
0,7x
|
|
Cellectis S.A.
|
CLLS
|
██%
|
$352M
|
x
|
x
|
|
Compass Therapeutics, Inc.
|
CMPX
|
██%
|
$963M
|
x
|
4,9x
|
|
Mosaic Immunoengineering Inc.
|
CPMV
|
██%
|
$5M
|
x
|
x
|
|
Caribou Biosciences, Inc.
|
CRBU
|
██%
|
$142M
|
-1,5x
|
1,0x
|
|
Cardiff Oncology, Inc.
|
CRDF
|
██%
|
$107M
|
x
|
2,4x
|
|
Cardiol Therapeutics Inc.
|
CRDL
|
██%
|
$144M
|
x
|
x
|
|
Curis Inc
|
CRIS
|
██%
|
$20M
|
x
|
3,7x
|
|
Crispr Therapeutics Ag
|
CRSP
|
██%
|
$4.96B
|
x
|
2,6x
|
|
Champions Oncology, Inc.
|
CSBR
|
██%
|
$84M
|
x
|
19,6x
|
|
Cel Sci Corp
|
CVM
|
██%
|
$37M
|
x
|
3,3x
|
|
Dbv Technologies S.A.
|
DBVT
|
██%
|
$1.27B
|
x
|
7,5x
|
|
Dbv Technologies S.A.
|
DBVTF
|
██%
|
$10K
|
x
|
0,0x
|
|
Ginkgo Bioworks Holdings, Inc.
|
DNA
|
██%
|
$400M
|
x
|
0,8x
|
|
Denali Therapeutics Inc.
|
DNLI
|
██%
|
$3.01B
|
x
|
3,0x
|
|
Precision Biosciences Inc
|
DTIL
|
██%
|
$144M
|
x
|
1,6x
|
|
Dyadic International Inc
|
DYAI
|
██%
|
$32M
|
x
|
26,1x
|
|
Editas Medicine, Inc.
|
EDIT
|
██%
|
$270M
|
x
|
9,9x
|
|
Eloxx Pharmaceuticals, Inc.
|
ELOX
|
██%
|
$360K
|
x
|
x
|
|
Elutia Inc.
|
ELUT
|
██%
|
$47M
|
0,9x
|
1,7x
|
|
Engene Holdings Inc.
|
ENGN
|
██%
|
$490M
|
x
|
1,7x
|
|
Entera Bio Ltd.
|
ENTX
|
██%
|
$54M
|
x
|
4,1x
|
|
Viskase Holdings, Inc.
|
ENZN
|
██%
|
$4M
|
x
|
x
|
|
Estrella Immunopharma, Inc.
|
ESLA
|
██%
|
$82M
|
x
|
x
|
|
Evaxion A/S
|
EVAX
|
██%
|
$34M
|
x
|
x
|
|
Exelixis, Inc.
|
EXEL
|
██%
|
$11.60B
|
14,8x
|
5,4x
|
|
Exozymes Inc.
|
EXOZ
|
██%
|
$88M
|
x
|
25,9x
|
|
Fate Therapeutics Inc
|
FATE
|
██%
|
$136M
|
x
|
0,7x
|
|
4d Molecular Therapeutics, Inc.
|
FDMT
|
██%
|
$516M
|
x
|
1,0x
|
|
Fennec Pharmaceuticals Inc.
|
FENC
|
██%
|
$219M
|
x
|
6,2x
|
|
Finch Therapeutics Group, Inc.
|
FNCH
|
██%
|
$13M
|
0,5x
|
0,9x
|
|
Futuretech Ii Acquisition Corp.
|
FTII
|
██%
|
$52M
|
x
|
x
|
|
Futuretech Ii Acquisition Corp.
|
FTIIU
|
██%
|
$14M
|
x
|
-0,8x
|
|
Gilead Sciences, Inc.
|
GILD
|
██%
|
$174.89B
|
20,6x
|
7,7x
|
|
Monte Rosa Therapeutics, Inc.
|
GLUE
|
██%
|
$1.40B
|
x
|
6,0x
|
|
Genenta Science S.P.A.
|
GNTA
|
██%
|
$16M
|
x
|
1,3x
|
|
Green Planet Bio Engineering Co. Ltd.
|
GPLB
|
██%
|
$340K
|
x
|
x
|
|
Greenland Mines Ltd
|
GRML
|
██%
|
$51M
|
x
|
5,1x
|
|
Halozyme Therapeutics, Inc.
|
HALO
|
██%
|
$7.90B
|
24,9x
|
161,9x
|
|
Humacyte, Inc.
|
HUMA
|
██%
|
$141M
|
x
|
45,3x
|
|
Immunitybio, Inc.
|
IBRX
|
██%
|
$7.35B
|
x
|
x
|
|
Inhibikase Therapeutics, Inc.
|
IKT
|
██%
|
$223M
|
x
|
1,3x
|
|
Imagenebio, Inc.
|
IMA
|
██%
|
$53M
|
x
|
0,4x
|
|
Immunocore Holdings Plc
|
IMCR
|
██%
|
$1.61B
|
x
|
4,2x
|
|
Immatics N.V.
|
IMTX
|
██%
|
$1.44B
|
x
|
x
|
|
Immunovant, Inc.
|
IMVT
|
██%
|
$5.22B
|
x
|
5,3x
|
|
In8bio, Inc.
|
INAB
|
██%
|
$15M
|
x
|
0,5x
|
|
Inhibrx Biosciences, Inc.
|
INBX
|
██%
|
$873M
|
-6,8x
|
109,2x
|
|
Mink Therapeutics, Inc.
|
INKT
|
██%
|
$55M
|
x
|
x
|
|
Inmune Bio, Inc.
|
INMB
|
██%
|
$34M
|
x
|
1,4x
|
|
Intensity Therapeutics, Inc.
|
INTS
|
██%
|
$14M
|
x
|
1,2x
|
|
Iovance Biotherapeutics, Inc.
|
IOVA
|
██%
|
$1.65B
|
x
|
2,4x
|
|
Century Therapeutics, Inc.
|
IPSC
|
██%
|
$414M
|
x
|
2,6x
|
|
Invivyd, Inc.
|
IVVD
|
██%
|
$502M
|
x
|
2,1x
|
|
Jasper Therapeutics, Inc.
|
JSPR
|
██%
|
$23M
|
x
|
5,5x
|
|
Kalaris Therapeutics, Inc.
|
KLRS
|
██%
|
$137M
|
x
|
1,7x
|
|
Klotho Neurosciences, Inc.
|
KLTO
|
██%
|
$56M
|
x
|
5,7x
|
|
Kodiak Sciences Inc.
|
KOD
|
██%
|
$2.64B
|
x
|
16,8x
|
|
Krystal Biotech, Inc.
|
KRYS
|
██%
|
$7.54B
|
36,8x
|
6,2x
|
|
Kymera Therapeutics, Inc.
|
KYMR
|
██%
|
$7.19B
|
x
|
4,6x
|
|
Kyverna Therapeutics, Inc.
|
KYTX
|
██%
|
$555M
|
x
|
2,4x
|
|
Ladrx Corp
|
LADX
|
██%
|
$20K
|
x
|
0,1x
|
|
Lineage Cell Therapeutics, Inc.
|
LCTX
|
██%
|
$368M
|
x
|
8,3x
|
|
Lenz Therapeutics, Inc.
|
LENZ
|
██%
|
$293M
|
x
|
1,0x
|
|
Liminatus Pharma, Inc.
|
LIMN
|
██%
|
$9M
|
x
|
x
|
|
Leonabio, Inc.
|
LONA
|
██%
|
$90M
|
x
|
3,2x
|
|
Lexeo Therapeutics, Inc.
|
LXEO
|
██%
|
$473M
|
x
|
1,9x
|
|
Maze Therapeutics, Inc.
|
MAZE
|
██%
|
$1.38B
|
x
|
3,9x
|
|
Mesoblast Ltd
|
MESO
|
██%
|
$1.92B
|
x
|
x
|
|
Meiragtx Holdings Plc
|
MGTX
|
██%
|
$759M
|
x
|
x
|
|
Metagenomi Therapeutics, Inc.
|
MGX
|
██%
|
$52M
|
x
|
0,3x
|
|
Molecular Partners Ag
|
MOLN
|
██%
|
$175M
|
x
|
x
|
|
Moderna, Inc.
|
MRNA
|
██%
|
$20.23B
|
x
|
2,3x
|
|
Neurocrine Biosciences Inc
|
NBIX
|
██%
|
$13.21B
|
27,6x
|
4,1x
|
|
Nkgen Biotech, Inc.
|
NKGN
|
██%
|
$2M
|
-0,1x
|
-0,2x
|
|
Neumora Therapeutics, Inc.
|
NMRA
|
██%
|
$362M
|
x
|
3,5x
|
|
Novavax Inc
|
NVAX
|
██%
|
$1.39B
|
3,2x
|
x
|
|
Ocugen, Inc.
|
OCGN
|
██%
|
$584M
|
x
|
x
|
|
Outlook Therapeutics, Inc.
|
OTLK
|
██%
|
$23M
|
x
|
x
|
|
Palisade Bio, Inc.
|
PALI
|
██%
|
$332M
|
x
|
2,6x
|
|
Passage Bio, Inc.
|
PASG
|
██%
|
$36M
|
x
|
1,9x
|
|
Vaxcyte, Inc.
|
PCVX
|
██%
|
$8.09B
|
x
|
3,0x
|
|
Biomx Inc.
|
PHGE
|
██%
|
$20M
|
x
|
x
|
|
Pluri Inc.
|
PLUR
|
██%
|
$34M
|
x
|
x
|
|
Protalix Biotherapeutics, Inc.
|
PLX
|
██%
|
$183M
|
x
|
3,8x
|
|
Pharmacyte Biotech, Inc.
|
PMCB
|
██%
|
$7M
|
x
|
0,2x
|
|
Prime Medicine, Inc.
|
PRME
|
██%
|
$634M
|
x
|
5,2x
|
|
Prokidney Corp.
|
PROK
|
██%
|
$572M
|
x
|
x
|
|
Pelthos Therapeutics Inc.
|
PTHS
|
██%
|
$73M
|
x
|
1,9x
|
|
Qiagen N.V.
|
QGEN
|
██%
|
$8.90B
|
x
|
2,4x
|
|
Quince Therapeutics, Inc.
|
QNCX
|
██%
|
$7M
|
x
|
6,4x
|
|
Qrons Inc.
|
QRON
|
██%
|
$150K
|
x
|
x
|
|
Replimune Group, Inc.
|
REPL
|
██%
|
$471M
|
x
|
2,2x
|
|
Repligen Corp
|
RGEN
|
██%
|
$6.75B
|
138,0x
|
3,2x
|
|
Regenxbio Inc.
|
RGNX
|
██%
|
$456M
|
x
|
4,4x
|
|
Relay Therapeutics, Inc.
|
RLAY
|
██%
|
$2.61B
|
x
|
4,6x
|
|
Revolution Medicines, Inc.
|
RVMD
|
██%
|
$18.96B
|
x
|
11,6x
|
|
Recursion Pharmaceuticals, Inc.
|
RXRX
|
██%
|
$1.75B
|
x
|
1,6x
|
|
Sab Biotherapeutics, Inc.
|
SABS
|
██%
|
$269M
|
20,3x
|
1,8x
|
|
Sana Biotechnology, Inc.
|
SANA
|
██%
|
$832M
|
x
|
5,2x
|
|
Scilex Holding Co
|
SCLX
|
██%
|
$49M
|
x
|
x
|
|
Scinai Immunotherapeutics Ltd.
|
SCNI
|
██%
|
$2M
|
x
|
0,3x
|
|
Sangamo Therapeutics, Inc
|
SGMO
|
██%
|
$108M
|
x
|
x
|
|
Solid Biosciences Inc.
|
SLDB
|
██%
|
$797M
|
x
|
4,4x
|
|
Silexion Therapeutics Corp
|
SLXN
|
██%
|
$4M
|
x
|
1,4x
|
|
Senti Biosciences, Inc.
|
SNTI
|
██%
|
$27M
|
x
|
4,8x
|
|
Scholar Rock Holding Corp
|
SRRK
|
██%
|
$5.34B
|
x
|
21,7x
|
|
Surrozen, Inc./De
|
SRZN
|
██%
|
$323M
|
x
|
x
|
|
Sutro Biopharma, Inc.
|
STRO
|
██%
|
$443M
|
x
|
x
|
|
Protara Therapeutics, Inc.
|
TARA
|
██%
|
$285M
|
x
|
1,5x
|
|
Tarsus Pharmaceuticals, Inc.
|
TARS
|
██%
|
$3.08B
|
x
|
9,0x
|
|
Tc Biopharm (Holdings) Plc
|
TCBPY
|
██%
|
$10K
|
x
|
0,0x
|
|
Tscan Therapeutics, Inc.
|
TCRX
|
██%
|
$60M
|
x
|
0,5x
|
|
Bio-Techne Corp
|
TECH
|
██%
|
$8.66B
|
106,8x
|
4,3x
|
|
Tectonic Therapeutic, Inc.
|
TECX
|
██%
|
$583M
|
x
|
2,3x
|
|
Instil Bio, Inc.
|
TIL
|
██%
|
$57M
|
x
|
0,5x
|
|
Tenaya Therapeutics, Inc.
|
TNYA
|
██%
|
$161M
|
x
|
1,3x
|
|
Tourmaline Bio, Inc.
|
TRML
|
██%
|
$1.23B
|
-3,5x
|
4,8x
|
|
Taysha Gene Therapies, Inc.
|
TSHA
|
██%
|
$1.32B
|
x
|
5,3x
|
|
Titan Pharmaceuticals Inc
|
TTNP
|
██%
|
$6M
|
-0,5x
|
2,2x
|
|
Tevogen Bio Holdings Inc.
|
TVGN
|
██%
|
$24M
|
x
|
x
|
|
Twist Bioscience Corp
|
TWST
|
██%
|
$2.99B
|
x
|
6,6x
|
|
Voyager Acquisition Corp./Cayman Islands
|
VACH
|
██%
|
$404M
|
44,9x
|
x
|
|
Voyager Acquisition Corp./Cayman Islands
|
VACHU
|
██%
|
$68M
|
6,7x
|
0,0x
|
|
Valneva Se
|
VALN
|
██%
|
$552M
|
x
|
x
|
|
Vericel Corp
|
VCEL
|
██%
|
$1.70B
|
102,9x
|
4,8x
|
|
Vir Biotechnology, Inc.
|
VIR
|
██%
|
$1.57B
|
x
|
2,1x
|
|
Vivosim Labs, Inc.
|
VIVS
|
██%
|
$4M
|
x
|
0,9x
|
|
Vor Biopharma Inc.
|
VOR
|
██%
|
$762M
|
x
|
x
|
|
Vaxart, Inc.
|
VXRT
|
██%
|
$152M
|
9,3x
|
1,7x
|
|
Voyager Therapeutics, Inc.
|
VYGR
|
██%
|
$234M
|
x
|
1,2x
|
|
Windtree Therapeutics Inc /De/
|
WINT
|
██%
|
$670K
|
x
|
x
|
|
X4 Pharmaceuticals, Inc
|
XFOR
|
██%
|
$370M
|
x
|
2,0x
|
|
Zeo Scientifix, Inc.
|
ZEOX
|
██%
|
$14M
|
x
|
x
|
|
Zivo Bioscience, Inc.
|
ZIVO
|
██%
|
$12M
|
x
|
x
|
|
Zura Bio Ltd
|
ZURA
|
██%
|
$531M
|
x
|
5,2x
|
